Media Event: |
Boehringer Ingelheim is actively developing promising compounds as new agents for combating diseases and with the aim of bridging therapeutic gaps. At our international R & D press conference on 08 November 2006 in Vienna, Austria, we provide insight into our Research and Development activities and pipeline. |
|---|---|
Venue: |
Vienna, 08 November 2006 |
Research & Development Press Conference on 08 November 2006
Background information for medical media outside the US only
-
Video/Podcast: R & D at Boehringer Ingelheim
-
Dr Andreas Barner
Vice-Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine
ASF Video length 3:36 min
-
Video: Highlights of the R&D press conference
Highlights of the
Boehringer Ingelheim
Research & Development press conferenceASF Video length 6:52 min
-
